Asset Details
Do you wish to reserve the book?
Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial
Do you wish to request the book?
Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial
2023
Overview
Nature Medicine
explores the latest translation and clinical research news, with a phase 3 trial from Merck and Moderna testing mRNA-4157 combined with pembrolizumab in melanoma.
Nature Medicine explores the latest translation and clinical research news, with a phase 3 trial from Merck and Moderna testing mRNA-4157 combined with pembrolizumab in melanoma.
Image credit: Denis Pobytov / DigitalVision Vectors / Getty
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
